![Griet Vanpoucke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Griet Vanpoucke
Director/Miembro de la Junta en Orionis Biosciences, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Nikolai Kley | M | - |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.
Orionis Biosciences BV
![]() Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | 9 años |
Mike Garrett | M | - |
Flamingo Therapeutics BV
![]() Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | 4 años |
Floor Stam | F | - |
Flamingo Therapeutics BV
![]() Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | 4 años |
Els Beirnaert | M | - |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | - |
Prabhavathi Fernandes | M | 74 |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | - |
Steve Gullans | M | 71 |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA.
Orionis Biosciences BV
![]() Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | - |
Joe Bolen | M | 70 |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | - |
Tim van Hauwermeiren | M | 52 |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | 6 años |
Jan Tavernier | M | - |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | - |
Anthony Fadell | M | 55 |
Orionis Biosciences BV
![]() Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | 1 años |
Tine Bekaert | F | - |
Flamingo Therapeutics BV
![]() Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | 2 años |
Ellie McGuire | F | - |
Montis Biosciences BV
![]() Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | - |
Rana Al-Hallaq | M | - |
Montis Biosciences BV
![]() Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | - |
Sohaib Mir | M | 42 |
Montis Biosciences BV
![]() Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | 5 años |
Robert G. Petit | M | 64 |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 2 años |
Matias de Tezanos | M | - |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 6 años |
Debasish Francois Roychowdhury | M | 63 |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | - |
James N. Kyranos | M | - |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 8 años |
Frank Kalkbrenner | M | - |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | - |
Luc Dochez | M | 49 |
Montis Biosciences BV
![]() Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | - |
John Paul de Koning | M | 55 |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | - |
Matias de Tezanos | M | 44 |
Orionis Biosciences, Inc.
![]() Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Orionis Biosciences, Inc. engages in operation of an biotechnology company that specializes in drug discovery. It offers A-Kine biologics and Allo-Glue, a small molecule platform with applications to the reprogramming of disease states. The company was founded by Nikolai Kley and Jan Tavernier and is headquartered in Waltham, MA. | 6 años |
Bihua Chen | F | 55 |
Orionis Biosciences BV
![]() Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | 3 años |
Bart De Taeye | M | - |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | 2 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Roderick Verhelst | M | - |
Flamingo Therapeutics BV
![]() Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | 1 años |
Jan Van den Bossche | M | - |
Aelin Therapeutics NV
![]() Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Bélgica | 21 | 80.77% |
Estados Unidos | 7 | 26.92% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Griet Vanpoucke
- Red Personal